2nd Translational Research Conference
Immune & Cellular Therapies:
Focus on Advanced Gene-Engineered Immune Cells
Chairs: Chiara Bonini, Michael Hudecek, Stan Riddell

2nd Translational Research Conference
Immune & Cellular Therapies:
Focus on Advanced Gene-Engineered Immune Cells
Information
ABOUT THE CONFERENCE:
The ESH 2nd Translational Research Conference on IMMUNE & CELLULAR THERAPIES: Focus on Advanced Gene-Engineered Immune Cells proposes a programme of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field.It is open to an international audience of biologists and clinicians, including those still in-training. This translational research conference will bring together biologists and clinicians with an interest in immune & cellular therapies with a focus on advanced gene-engineered immune cells.New data will be presented and spirited debates on how to best to apply these insights to the future of immune & cellular therapies are expected.
SCIENTIFIC TOPICS:
• Updates in CAR T Cell therapy for B-Cell tumours
• CAR T Cell therapies for acute myeloid leukaemia and multiple myeloma
• Management of resistance and toxicity to CAR T Cells
• Bites and other engineered antibody therapies
• Cellular therapies for infections• Non-T Cell therapies (MSC, Gamma-Delta T-Cells, etc.)
• Immune therapy strategies for solid tumours
• Cellular therapies for GVHD (SC, Suicide Genes, etc.)
Programme
Read the final programme!


